The effect of commercial vasoconstrictor preparations on the circulating venous serum level of mepivacaine and lidocaine.
D000328:Adult; D005260:Female; D006801:Humans; D008012:Lidocaine / Q000097:blood*; D008297:Male; D008619:Mepivacaine / Q000097:blood*; D014662:Vasoconstrictor Agents / Q000097:blood / Q000494:pharmacology*
D014662:Vasoconstrictor Agents; D008012:Lidocaine; D008619:Mepivacaine